<DOC>
	<DOCNO>NCT01795599</DOCNO>
	<brief_summary>More 100 000 surgical abortion annually perform France . About four ten woman abortion life . Abortion complication cervical tearing ( 0.1-1.18 % ) , uterine perforation ( 0.09-19.8‰ ) , hemorrhage ( 1.5‰ ) infection ( 5-20 % ) . These complication first compromise vital prognosis involve 10 % worldwide maternal mortality ( 20 000 woman year ) , lead infertility hard treat ( uterine synechiae ) impossible treat ( hysterectomy control bleed ) , finally responsible obstetrical pathology late miscarriage premature delivery due cervical insufficiency . All complication link cervical laceration surgical abortion , reduce recommend use mifepristone misoprostol cervical preparation abortion 12 week . However , exist data evaluate superiority one two molecule combination . These data could optimize cervical preparation thus reduce abortion complication direct impact maternal mortality , infertility obstetrical complication . Thus , seem important evaluate two molecule combination . Objectives To compare mifepristone , misoprostol combination cervical preparation surgical abortion 12 and14 week efficacy , complication side-effects .</brief_summary>
	<brief_title>Cervical Preparation Surgical Abortion 12-14 Weeks : Prospective , Randomized , Evaluator-blinded , Multicenter , Controlled Comparison Between Mifepristone , Misoprostol Their Combination</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Woman 18 year old ; Woman present intrauterine pregnancy , term upper 11 LIMITED COMPANIES 6 day inferior strictly 14 LIMITED COMPANIES , estimate ( esteem ) echography measure crâniocaudal length include 55 84 millimeter ; ·Woman wish TERMINATION OF PREGNANCY ; minor Woman ; Woman present multiple pregnancy ; Woman present uterine deformation ( compartmentalize womb , cock hat , fibroid praevia ) ; Woman present disorder coagulation define biological parameter ( TP ( BUSINESS RATE , PRACTICAL CLASS , PRACTICAL CLASSES ) &lt; 70 % , TCA report ( relationship ) patient / witness &lt; 1,20 ) ; Woman present allergy sentimentality know one active substance one excipients ; Woman present contraindication mifepristone : chronic suprarenal insufficiency , unchecked severe asthma treatment ( process ) , porphyrie hereditary , allergy know active substance one excipients ; Woman present contraindication misoprostol : sentimentality active substance , one excipients prostaglandines ;</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>